References
- Mantegazza R, Bemasconi P. Cellular aspects of myositis. CUff Opin Rheumatol. 1994;6:568–74.
- Kikuchi Y, Koarada S, Tada Y, Ushiyama O, Morito F, Suzuki N, et al. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis. 2001;60:1137–40.
- Dalakas MC. Molecular immunology and genetics of inflamma-tory muscle diseases. Arch Neurol. 1998;55:1509–12.
- Eisenstein DM, O'Gorman MR, Pachman LM. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomy-ositis. J Rheumatol. 1997;24:1830–2.
- O'Gorman MR, Bianchi L, Zoos D, Conochano V, Pachman LM. Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile der-matomyositis. Clin Diagn Lab Immunol. 2000;7:693–7.
- Robinson AB, Reed AM. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol. 2011;7:664–75.
- Gunawardena H, Wedderbum LR, North J, Betteridge Z, Dunphy J, Chinoy H, et al. Juvenile Dermatomyositis Research Group UK. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 2008;47:324–8.
- Koji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007; 46:25–8.
- Morbach H, Wiegering V, Richl P, Schwarz T, Suffa N, Eichhom EM, et al. Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis. Arthr Rheum. 2011;63:3458–66.
- Mizuno K, Yachie A, Nagaoki S, Wada H, Okada K, Kawachi M, et al. Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome. Clin Exp Immunol. 2004;137(1): 187–94.
- Bader-Meunier B, Decaluwe H, Bamerias C, Gherardi R, Quar-tier P, Faye A, Club Rhumatismes et Inflammation, et al. Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French autoimmunity and rit-uximab registry. J Rheumatol. 2011;38: 1436–40.
- Lopez De Padilla CM, Vallejo AN, Lacomis D, McNallan K, Reed AM. Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyo-sitis. Arthr Rheum. 2009;60:1160–72.
- Morva A, Lemoine S, Achour A, Pers JO, Youinou P, Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood. 2012;119:106–14.
- Morbach H, Eichhom EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol. 2010;162:271–9.
- Smet J, Mascart F, Schandene L. Are the reference values of B cell subpopulations used in adults for classification of common variable immunodeficiencies appropriate for children? Clin Immunol. 2011;138:266–73.
- Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, et al. Myositis-specific anti-155/140 autoantibodies target transcriptional intermediary factor 1 family proteins. Arthr Rheum. 2012;64:513–22.
- Krystufková O, Vallerskog T, Helmers SB, Mann H, Putová I, BeMeek J, et al. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis. 2009;68:836–43.